Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer
 
Sponsor
BioCis Pharma Ltd.

Collaborators
Turku University Hospital
Tampere University Hospital
FinnMedi Oy

 
Principal Investigator
Juha Peltonen, MD
CRST (Clinical Research Services Turku)

Contacts
Lasse Leino, PhD
358 40 849 4694
[email protected]


Continue Reading

Jarmo Laihia, PhD
358 40 865 1616
[email protected]

 
ClinicalTrials.gov Identifier
NCT01458847